Statements (126)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:are |
gptkb:theorem
|
| gptkbp:brand |
gptkb:drug
|
| gptkbp:can_be |
food or without food
without a prescription in some regions |
| gptkbp:can_be_used_with |
gptkb:product
unprotected sex other contraceptive methods other forms of contraception for best results |
| gptkbp:caused_by |
menstrual changes
changes in menstrual cycle |
| gptkbp:clinical_trial |
in many countries
|
| gptkbp:contains |
gptkb:levonorgestrel
|
| gptkbp:contraindication |
gptkb:theorem
|
| gptkbp:covered_by |
health insurance plans
all insurance plans |
| gptkbp:developed_by |
gptkb:Women’s_Health_Initiative
gptkb:Teva_Pharmaceuticals |
| gptkbp:discusses |
in media and literature
in sexual education programs |
| gptkbp:dosage_form |
nan
single pill |
| gptkbp:form |
postcoital contraception
|
| https://www.w3.org/2000/01/rdf-schema#label |
Plan B
|
| gptkbp:ingredients |
gptkb:levonorgestrel
|
| gptkbp:is_a |
regular contraceptive method
substitute for regular contraceptives |
| gptkbp:is_a_way_to |
birth control
|
| gptkbp:is_accessible_by |
women of reproductive age
|
| gptkbp:is_arepresentation_of |
regular contraceptive methods
|
| gptkbp:is_associated_with |
reduced risk of unintended pregnancy
|
| gptkbp:is_available_in |
gptkb:various_countries
worldwide many countries pharmacies generic forms generic form online pharmacies |
| gptkbp:is_available_on |
gptkb:drug
in pharmacies a single pill in various strengths over-the-counter in some places |
| gptkbp:is_considered |
safe for most women
a backup method a safe option for emergency contraception a critical option for reproductive rights |
| gptkbp:is_designed_to |
long-term contraception
regular birth control |
| gptkbp:is_different_from |
gptkb:RU-486
|
| gptkbp:is_discussed_in |
healthcare settings
sexual health education sexual health conversations |
| gptkbp:is_effective_against |
gptkb:theorem
abortion already pregnant most women overweight women preventing ovulation existing pregnancies for women over a certain weight taken after ovulation has occurred |
| gptkbp:is_known_for |
gptkb:Plan_B_One-Step
the morning-after pill |
| gptkbp:is_linked_to |
reproductive rights debates
|
| gptkbp:is_often_associated_with |
family planning discussions
the morning-after pill |
| gptkbp:is_often_depicted_as |
gptkb:RU-486
abortion pill an abortion pill |
| gptkbp:is_often_used_in |
young adults
|
| gptkbp:is_part_of |
reproductive health services
contraceptive counseling contraceptive options family planning methods reproductive health education reproductive health discussions women's health care. emergency contraception options |
| gptkbp:is_promoted_by |
women's health organizations
by health organizations family planning organizations |
| gptkbp:is_protected_by |
sexually transmitted infections
ST Is |
| gptkbp:is_subject_to |
regulatory approval
public health policies age restrictions in some areas |
| gptkbp:is_used_by |
contraceptive failure
millions of women annually |
| gptkbp:is_used_for |
women of reproductive age
preventing pregnancy after contraceptive failure |
| gptkbp:is_used_in |
sexual assault
|
| gptkbp:key |
emergency contraceptive options
|
| gptkbp:manufacturer |
gptkb:Teva_Pharmaceuticals
in various formulations |
| gptkbp:marketed_as |
various brand names
|
| gptkbp:non_comedogenic |
many regions
|
| gptkbp:notable_for |
emergency contraceptive option
|
| gptkbp:pharmacokinetics |
many countries
|
| gptkbp:preceded_by |
unprotected intercourse
|
| gptkbp:requires |
in some countries
|
| gptkbp:security_features |
most women
|
| gptkbp:side_effect |
dizziness
fatigue headache nausea breast tenderness |
| gptkbp:subject |
controversy in reproductive rights
|
| gptkbp:suitable_for |
healthcare providers
men women with certain health conditions routine use for emergency situations regular contraceptive use for routine use for use after unprotected sex women with allergies to its ingredients |
| gptkbp:takes_place_in |
72 hours after unprotected intercourse
|
| gptkbp:technique |
nan
|
| gptkbp:type_of |
gptkb:drug
|
| gptkbp:uses |
by individuals of reproductive age
|
| gptkbp:bfsParent |
gptkb:H._E._Megan_Thee_Stallion
gptkb:Rag'n'_Bone_Man |
| gptkbp:bfsLayer |
3
|